Drugplain

NUVARING .015 mg/d

etonogestrel and ethinyl estradiol · INSERT, EXTENDED RELEASE · A-S Medication Solutions

No Recall HistoryCurrently in Shortage
Plain English

NUVARING is a insert, extended release containing etonogestrel and ethinyl estradiol at .015 mg/d, taken vaginal. Manufactured by A-S Medication Solutions.

Key Facts

Brand Name
NUVARING
Generic Name
etonogestrel and ethinyl estradiol
NDC Code (Product)
50090-5611
Manufacturer
A-S Medication Solutions
Strength
.015 mg/d
Dosage Form
INSERT, EXTENDED RELEASE
Route
VAGINAL
Marketing Status
Application #
NDA021187
Drug Class
Estrogen [EPC]; Progestin [EPC]
Marketing Start
06/01/2021

Recall History

No Recall History

Frequently Asked Questions

What is NUVARING used for?

NUVARING contains etonogestrel and ethinyl estradiol. It is a insert, extended release taken vaginal. Consult your doctor for specific uses.

Is NUVARING a controlled substance?

NUVARING is not classified as a controlled substance by the DEA.

What is the generic name for NUVARING?

The generic name for NUVARING is etonogestrel and ethinyl estradiol. There are 9 other brand versions of etonogestrel and ethinyl estradiol.

What is the NDC code for NUVARING .015 mg/d?

The NDC (National Drug Code) for NUVARING .015 mg/d is 50090-5611, listed by A-S Medication Solutions.